Back to News
Market Impact: 0.15
Leerink Partners Initiates Coverage of Vera Therapeutics at Market Perform
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
Leerink Partners initiated coverage of Vera Therapeutics with a Market Perform recommendation on October 12, 2026. Vera's latest close that day was $27.75; the article provides no price reaction or additional rationale.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
VERA0.00
More News
- We're upgrading our Goldman Sachs rating after a strong quarter bodes well for the future
- We're upgrading our rating on Wells Fargo as the stock's pullback offers a nice entry point
- Talos Energy 10% owner sells $106.8m in shares
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
- This ugly shoe brand won over Gen Z. Its stock's low valuation could earn investors' attention
- UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs